Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease.

Vaziri, Nosratola

Advanced chronic kidney disease (CKD) results in a constellation of dysregulation of lipid metabolism, oxidative stress, and inflammation which are causally interconnected and participate in a vicious cycle. The CKD-associated lipid disorders are marked by impaired clearance of very low density lipoprotein and chylomicrons, hypertriglyceridemia, formation of small dense low-density lipoprotein (LDL), oxidative modification of LDL, intermediate density lipoprotein and chylomicron remnants, and high-density lipoprotein deficiency and dysfunction. This review provides a brief overview of the role of CKD-induced lipid disorders in the pathogenesis of oxidative stress, inflammation, cardiovascular disease, impaired exercise capacity, cachexia and wasting syndrome.

CHRONIC kidney failure; CARDIOVASCULAR diseases; DYSLIPIDEMIA; OXIDATIVE stress; LIPID metabolism; LOW density lipoproteins; HYPERTRIGLYCERIDEMIA; INFLAMMATION

Clinical & Experimental Nephrology, 2014, Vol 18, Issue 2, p265

1342-1751

Academic Journal

10.1007/s10157-013-0847-z